Published in Crit Care Med on March 01, 2009
β-adrenergic receptor-mediated cardiac contractility is inhibited via vasopressin type 1A-receptor-dependent signaling. Circulation (2014) 1.52
A Selective V1A Receptor Agonist, Selepressin, Is Superior to Arginine Vasopressin and to Norepinephrine in Ovine Septic Shock. Crit Care Med (2016) 1.49
Bench-to-bedside review: Vasopressin in the management of septic shock. Crit Care (2011) 1.17
The role of vasoactive agents in the resuscitation of microvascular perfusion and tissue oxygenation in critically ill patients. Intensive Care Med (2010) 0.95
A role for BK channels in heart rate regulation in rodents. PLoS One (2010) 0.94
Year in review 2009: Critical Care--shock. Crit Care (2010) 0.78
The effects of terlipressin on regional hemodynamics and kidney function in experimental hyperdynamic sepsis. PLoS One (2012) 0.78
Treatment and management of ascites and hepatorenal syndrome: an update. Therap Adv Gastroenterol (2015) 0.77
Effects of terlipressin and naloxone compared with epinephrine in a rat model of asphyxia-induced cardiac arrest. Clinics (Sao Paulo) (2013) 0.76
Terlipressin or europressin? Crit Care (2009) 0.76
Pharmacological characterization of FE 201874, the first selective high affinity rat V1A vasopressin receptor agonist. Br J Pharmacol (2013) 0.75
Terlipressin--more than just a prodrug of lysine vasopressin? Crit Care Med (2009) 0.75
The cAMP binding protein Epac modulates Ca2+ sparks by a Ca2+/calmodulin kinase signalling pathway in rat cardiac myocytes. J Physiol (2007) 1.85
Incidence, risk factors, and prognosis of a moderate increase in plasma creatinine early after cardiac surgery. Crit Care Med (2002) 1.74
Ca2+-dependent reduction of IK1 in rat ventricular cells: a novel paradigm for arrhythmia in heart failure? Cardiovasc Res (2005) 1.69
Increased Ca2+ sensitivity of the ryanodine receptor mutant RyR2R4496C underlies catecholaminergic polymorphic ventricular tachycardia. Circ Res (2008) 1.67
Leaky RyR2 trigger ventricular arrhythmias in Duchenne muscular dystrophy. Proc Natl Acad Sci U S A (2010) 1.67
Carbon monoxide induces cardiac arrhythmia via induction of the late Na+ current. Am J Respir Crit Care Med (2012) 1.50
Mechanisms of [Ca2+]i transient decrease in cardiomyopathy of db/db type 2 diabetic mice. Diabetes (2006) 1.49
Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents. Prog Brain Res (2008) 1.43
Intrahypothalamic angiogenesis induced by osmotic stimuli correlates with local hypoxia: a potential role of confined vasoconstriction induced by dendritic secretion of vasopressin. Endocrinology (2008) 1.42
Β-adrenergic blockade combined with subcutaneous B-type natriuretic peptide: a promising approach to reduce ventricular arrhythmia in heart failure? Heart (2014) 1.40
Akt regulates L-type Ca2+ channel activity by modulating Cavalpha1 protein stability. J Cell Biol (2009) 1.28
Locking the dimeric GABA(B) G-protein-coupled receptor in its active state. J Neurosci (2004) 1.25
A single olfactory receptor specifically binds a set of odorant molecules. Eur J Neurosci (2002) 1.25
Paradoxical effect of increased diastolic Ca(2+) release and decreased sinoatrial node activity in a mouse model of catecholaminergic polymorphic ventricular tachycardia. Circulation (2012) 1.19
Characterization of (2S,4R)-1-[5-chloro-1-[(2,4-dimethoxyphenyl)sulfonyl]-3-(2-methoxy-phenyl)-2-oxo-2,3-dihydro-1H-indol-3-yl]-4-hydroxy-N,N-dimethyl-2-pyrrolidine carboxamide (SSR149415), a selective and orally active vasopressin V1b receptor antagonist. J Pharmacol Exp Ther (2002) 1.16
Mineralocorticoid modulation of cardiac ryanodine receptor activity is associated with downregulation of FK506-binding proteins. Circulation (2009) 1.14
Cardiomyocyte overexpression of neuronal nitric oxide synthase delays transition toward heart failure in response to pressure overload by preserving calcium cycling. Circulation (2008) 1.12
Conditional FKBP12.6 overexpression in mouse cardiac myocytes prevents triggered ventricular tachycardia through specific alterations in excitation-contraction coupling. Circulation (2008) 1.04
Conopressin-T from Conus tulipa reveals an antagonist switch in vasopressin-like peptides. J Biol Chem (2008) 1.02
FKBP12.6 overexpression decreases Ca2+ spark amplitude but enhances [Ca2+]i transient in rat cardiac myocytes. Am J Physiol Heart Circ Physiol (2004) 1.01
Effects of amiodarone and dronedarone on voltage-dependent sodium current in human cardiomyocytes. J Cardiovasc Electrophysiol (2003) 1.01
Heparin binding EGF is necessary for vasospastic response to endothelin. FASEB J (2006) 1.00
A cyclic peptide mimicking the third intracellular loop of the V2 vasopressin receptor inhibits signaling through its interaction with receptor dimer and G protein. J Biol Chem (2004) 1.00
Mineralocorticoid receptor antagonism prevents the electrical remodeling that precedes cellular hypertrophy after myocardial infarction. Circulation (2004) 0.98
cGMP-dependent protein kinase type II regulates basal level of aldosterone production by zona glomerulosa cells without increasing expression of the steroidogenic acute regulatory protein gene. J Biol Chem (2003) 0.97
Ca2+ current-mediated regulation of action potential by pacing rate in rat ventricular myocytes. Cardiovasc Res (2003) 0.95
Hypothalamic vasopressin release and hepatocyte Ca2+ signaling during liver regeneration: an interplay stimulating liver growth and bile flow. FASEB J (2003) 0.91
Altered communication between L-type calcium channels and ryanodine receptors in heart failure. Front Biosci (2002) 0.91
A direct relationship between plasma aldosterone and cardiac L-type Ca2+ current in mice. J Physiol (2005) 0.91
Carbon monoxide pollution promotes cardiac remodeling and ventricular arrhythmia in healthy rats. Am J Respir Crit Care Med (2009) 0.90
Ca2+ controls functional expression of the cardiac K+ transient outward current via the calcineurin pathway. J Biol Chem (2004) 0.89
New drugs vs. old concepts: a fresh look at antiarrhythmics. Pharmacol Ther (2011) 0.89
Affinity and efficacy of selective agonists and antagonists for vasopressin and oxytocin receptors: an "easy guide" to receptor pharmacology. Prog Brain Res (2008) 0.87
New insights into sexual dimorphism during progression of heart failure and rhythm disorders. Endocrinology (2010) 0.87
Functional and pharmacological characterization of the first specific agonist and antagonist for the V1b receptor in mammals. Stress (2003) 0.87
Neuropeptide Y rapidly enhances [Ca2+]i transients and Ca2+ sparks in adult rat ventricular myocytes through Y1 receptor and PLC activation. J Mol Cell Cardiol (2004) 0.86
Remodelling of calcium signalling during liver regeneration in the rat. J Hepatol (2006) 0.86
Subendocardial increase in reactive oxygen species production affects regional contractile function in ischemic heart failure. Antioxid Redox Signal (2012) 0.85
Frequency-dependent and proarrhythmogenic effects of FK-506 in rat ventricular cells. Am J Physiol Heart Circ Physiol (2004) 0.85
Design and synthesis of the first selective agonists for the rat vasopressin V(1b) receptor: based on modifications of deamino-[Cys1]arginine vasopressin at positions 4 and 8. J Med Chem (2007) 0.84
Pharmacological and physiological characterization of d[Leu4, Lys8]vasopressin, the first V1b-selective agonist for rat vasopressin/oxytocin receptors. Endocrinology (2007) 0.84
Mutant cardiac ryanodine receptors and ventricular arrhythmias: is 'gain-of-function' obligatory? Cardiovasc Res (2004) 0.84
V1b and CRHR1 receptor heterodimerization mediates synergistic biological actions of vasopressin and CRH. Mol Endocrinol (2012) 0.84
Carbon monoxide exposure enhances arrhythmia after cardiac stress: involvement of oxidative stress. Basic Res Cardiol (2011) 0.83
Mapping the binding site of arginine vasopressin to V1a and V1b vasopressin receptors. Mol Endocrinol (2006) 0.83
Protection against hypoxic-ischemic injury in transgenic mice overexpressing Kir6.2 channel pore in forebrain. Mol Cell Neurosci (2004) 0.83
Design of potent and selective agonists for the human vasopressin V1b receptor based on modifications of [deamino-cys1]arginine vasopressin at position 4. J Med Chem (2004) 0.82
New insights in the contribution of voltage-gated Na(v) channels to rat aorta contraction. PLoS One (2009) 0.82
Post cardiac surgery vasoplegia is associated with high preoperative copeptin plasma concentration. Crit Care (2011) 0.81
Sustained elevated levels of circulating vasopressin selectively stimulate the proliferation of kidney tubular cells via the activation of V2 receptors. Endocrinology (2008) 0.81
Active peptidic mimics of the second intracellular loop of the V(1A) vasopressin receptor are structurally related to the second intracellular rhodopsin loop: a combined 1H NMR and biochemical study. Biochemistry (2003) 0.81
The RNA-binding protein RBPMS2 regulates development of gastrointestinal smooth muscle. Gastroenterology (2012) 0.81
Unzipping RyR2 in adult cardiomyocytes: getting closer to mechanisms of inherited ventricular arrhythmias? Cardiovasc Res (2006) 0.80
Engagement of β-arrestin by transactivated insulin-like growth factor receptor is needed for V2 vasopressin receptor-stimulated ERK1/2 activation. Proc Natl Acad Sci U S A (2012) 0.80
RyRCa2+ leak limits cardiac Ca2+ window current overcoming the tonic effect of calmodulinin mice. PLoS One (2011) 0.80
Permissive effect of voltage on mGlu 7 receptor subtype signaling in neurons. J Biol Chem (2001) 0.80
Pharmacological characterization of F-180: a selective human V(1a) vasopressin receptor agonist of high affinity. Br J Pharmacol (2002) 0.80
Morphine mimics the antiapoptotic effect of preconditioning via an Ins(1,4,5)P3 signaling pathway in rat ventricular myocytes. Am J Physiol Heart Circ Physiol (2004) 0.80
Design, synthesis, and pharmacological characterization of fluorescent peptides for imaging human V1b vasopressin or oxytocin receptors. J Med Chem (2011) 0.80
Polyphenols prevent lipid abnormalities and arterial dysfunction in hamsters on a high-fat diet: a comparative study of red grape and white persimmon wines. Food Funct (2011) 0.79
Cardiomyocytes hypertrophic status after myocardial infarction determines distinct types of arrhythmia: role of the ryanodine receptor. Prog Biophys Mol Biol (2010) 0.79
Functional evidence for an active role of B-type natriuretic peptide in cardiac remodelling and pro-arrhythmogenicity. Cardiovasc Res (2012) 0.79
Nitric oxide pathway counteracts enhanced contraction to membrane depolarization in aortic rings of rats on high-sodium diet. Am J Physiol Regul Integr Comp Physiol (2006) 0.78
Inducible nitric-oxide synthase attenuates vasopressin-dependent Ca2+ signaling in rat hepatocytes. J Biol Chem (2002) 0.78
Vasopressin inhibits LTP in the CA2 mouse hippocampal area. PLoS One (2012) 0.77
Vasopressin-induced morphological changes in polarized rat hepatocyte multiplets: dual calcium-dependent effects. Cell Calcium (2007) 0.77
Design and synthesis of cyclic and linear peptide-agarose tools for baiting interacting protein partners of GPCRs. Bioorg Med Chem Lett (2005) 0.77
Prolongation in QT interval is not predictive of Ca2+-dependent arrhythmias: implications for drug safety. Expert Opin Drug Saf (2009) 0.77
Endothelin-dependent vasoconstriction in human uterine artery: application to preeclampsia. PLoS One (2011) 0.77
Position 4 analogues of [deamino-Cys(1)] arginine vasopressin exhibit striking species differences for human and rat V(2)/V(1b) receptor selectivity. J Pept Sci (2006) 0.77
The multifunctional protein GC1q-R interacts specifically with the i3 loop arginine cluster of the vasopressin V2 receptor. Regul Pept (2008) 0.77
Myocardial expression of a dominant-negative form of Daxx decreases infarct size and attenuates apoptosis in an in vivo mouse model of ischemia/reperfusion injury. Circulation (2007) 0.77
[Ryanodine receptor and heart disease]. Med Sci (Paris) (2008) 0.76
NADPH oxidase activity is associated with cardiac osteopontin and pro-collagen type I expression in uremia. Free Radic Res (2010) 0.76
Hypovolaemia-induced vasodilatation during angiotensin AT1 receptor blockade: role of the AT2 receptor. Pharmacol Res (2005) 0.76
Comparative pharmacology of bovine, human and rat vasopressin receptor isoforms. Eur J Pharmacol (2004) 0.75
Pharmacological characterization of FE 201874, the first selective high affinity rat V1A vasopressin receptor agonist. Br J Pharmacol (2013) 0.75
From funny current to current physiome. Prog Biophys Mol Biol (2005) 0.75
Bifocal tuberculosis highlighted by obstetric combined spinal-epidural analgesia. Anesthesiology (2005) 0.75
Effect of Impella During Veno-Arterial Extracorporeal Membrane Oxygenation on Pulmonary Artery Flow as Assessed by End-Tidal Carbon Dioxide. ASAIO J (2017) 0.75
Cumulative effects of AT1 and AT2 receptor blockade on ischaemia-reperfusion recovery in rat hearts. Pharmacol Res (2005) 0.75
Delayed pulmonary arterial hypertension in relation to pulmonary damage score after pneumonectomy under protective ventilation: experimental study. Eur Surg Res (2013) 0.75
Use of 3D surface scanning to match facial shapes against altered exhumed remains in a context of forensic individual identification. Forensic Sci Med Pathol (2014) 0.75
Corrigendum: Inter-individual variability and modeling of electrical activity: a possible new approach to explore cardiac safety? Sci Rep (2017) 0.75